standard management

PreclinicalSmall molecule

UUniversity Hospital, Rouen

standard management is one of 69 small molecule programs targeting Pneumonia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PneumoniaActive, not recruiting

Back PainActive, not recruiting

PneumoniaPreclinical

Active, not recruiting

Back PainPreclinical

Active, not recruiting

Competition

Competitive Landscape

155 competitors in Pneumonia

#DrugCompanyPhaseTrials

Jakafi

Incyte

Preclinical

1 2

Primaquine

Sanofi

Preclinical

1 3

Acanya

Pfizer

Preclinical

1 4

Avlosulfon

AAlmirall, S.A.

Preclinical

4 5

Retrovir

BBp Consulting, Inc

Preclinical

2 6

Primsol

CConrado Roberto Hoffmann Filho

Preclinical

2 7

Virazole

CConrado Roberto Hoffmann Filho

Preclinical

2 8

Advil

KKenvue Brands

Preclinical

2 9

Pepcid

KKenvue Brands

Preclinical

1 10

Aciphex

Akero Therapeutics

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2032

Phase 3Not yet recruiting

Colorectal Cancer

NCT06446557

Clinical

Trials by Indication[1]

Digestive Cancer1 trial

Equivalence of Monitoring by a Nurse Practitioner for Patients With Digestive Cancer

Completed·UUniversity Hospital, Rouen·Phase 3·NCT02956876·207 enrolled

Back pain1 trial

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

Completed·UUniversity of Baghdad·N/A·NCT06064058·90 enrolled

Colorectal Cancer1 trial

De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer

Not yet recruiting·UUniversity Hospital, Rouen·Phase 3·NCT06446557·408 enrolled

Pneumonia1 trial

Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care

Recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT05124977·590 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for standard management. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — standard management compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for standard management. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Rouen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital, Rouen

standard management

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2032

Trials by Indication[1]

Digestive Cancer1 trial

Back pain1 trial

Colorectal Cancer1 trial

Pneumonia1 trial

References

Drug Info

Quick Facts

Related News